JANX
Janux Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.24
+2.22%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+49.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | Campbell David Alan · director, officer: President and CEO | M-Exempt | 7,000 | $4.21 |
| Jun 12, 2026 | Kung Winston · director | A-Award | 5,500 | $0.00 |
| Jun 12, 2026 | CAPPS VICKIE L · director | A-Award | 5,500 | $0.00 |
| Jun 12, 2026 | Hernday Natasha · director | A-Award | 5,500 | $0.00 |
| Jun 12, 2026 | Hernday Natasha · director | A-Award | 15,500 | $14 |
| Jun 12, 2026 | DOBMEIER ERIC · director | A-Award | 5,500 | $0.00 |
| Jun 12, 2026 | DOBMEIER ERIC · director | A-Award | 15,500 | $14 |
| Jun 12, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 5,500 | $0.00 |
| Jun 12, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 15,500 | $14 |
| Jun 12, 2026 | Simson Jake · director | A-Award | 5,500 | $0.00 |
| Jun 12, 2026 | Simson Jake · director | A-Award | 15,500 | $14 |
| Jun 12, 2026 | CAPPS VICKIE L · director | A-Award | 15,500 | $14 |
| Jun 12, 2026 | Barrett Ronald W · director | A-Award | 5,500 | $0.00 |
| Jun 12, 2026 | Barrett Ronald W · director | A-Award | 15,500 | $14 |
| Jun 12, 2026 | Kung Winston · director | A-Award | 15,500 | $14 |
| Jun 4, 2026 | Doyle Janeen Noel · officer: Chief Corp. & Bus. Dev. Ofcr | Sale | 4,059 | $14 |
| May 13, 2026 | Dobek Maria · officer: Vice President, Accounting | Sale | 2,038 | $14 |
| Feb 4, 2026 | Go William · officer: Chief Medical Officer | A-Award | 154,000 | $14 |
| Feb 4, 2026 | Go William · officer: Chief Medical Officer | A-Award | 44,000 | $0.00 |
| Jan 2, 2026 | Dobek Maria · officer: Vice President, Accounting | A-Award | 42,600 | $14 |
| Jan 2, 2026 | Dobek Maria · officer: Vice President, Accounting | A-Award | 18,935 | $0.00 |
| Jan 2, 2026 | Campbell David Alan · director, officer: President and CEO | A-Award | 96,600 | $0.00 |
| Jan 2, 2026 | DiRaimondo Thomas · officer: Chief Scientific Officer | A-Award | 109,900 | $14 |
| Jan 2, 2026 | DiRaimondo Thomas · officer: Chief Scientific Officer | Sale | 2,505 | $14 |
| Jan 2, 2026 | DiRaimondo Thomas · officer: Chief Scientific Officer | A-Award | 31,400 | $0.00 |
| Jan 2, 2026 | Meyer Andrew Hollman · officer: Chief Business Officer | Sale | 1,879 | $14 |
| Jan 2, 2026 | Dobek Maria · officer: Vice President, Accounting | Sale | 1,462 | $14 |
| Jan 2, 2026 | Campbell David Alan · director, officer: President and CEO | A-Award | 338,100 | $14 |
| Jan 2, 2026 | Campbell David Alan · director, officer: President and CEO | Sale | 8,072 | $14 |
| Jan 2, 2026 | Winter Charles M. · officer: Chief Technical Officer | A-Award | 28,600 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 88Increased 151Reduced 102Sold out 30
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 11,189,693 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 11,189,693 | May 15, 2026 |
| BlackRock, Inc. | Increased | 6,134,667 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 5,433,233 | May 13, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 4,196,409 | May 18, 2026 |
| Prosight Management, LP | Increased | 3,804,481 | Aug 14, 2026 |
| PROSIGHT MANAGEMENT, LP | Increased | 3,550,000 | May 15, 2026 |
| STATE STREET CORP | Increased | 3,004,899 | Aug 7, 2026 |
| FMR LLC | Reduced | 2,535,724 | May 15, 2026 |
| STATE STREET CORP | Reduced | 2,464,017 | May 15, 2026 |
| FMR LLC | Reduced | 2,412,825 | Aug 13, 2026 |
| FEDERATED HERMES, INC. | Increased | 2,352,927 | Aug 12, 2026 |
| Point72 Asset Management, L.P. | Increased | 1,993,837 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,857,351 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,811,365 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 10, 2026